Pooled Analysis of Cardiovascular Safety With Fremanezumab Treatment in Patients With Migraine by Number of Cardiovascular or Cerebrovascular Risk Factors

被引：0
|
作者：
Juergens, T. P. [1 ]
Ning, X. [2 ]
Kessler, Y. [2 ]
Cohen, J. M. [3 ]
Yang, R. [2 ]
Diener, H. [4 ]
机构：
[1] Univ Med Ctr Rostock, Headache Ctr North East, Dept Neurol, Rostock, Mecklenburg Vor, Germany
[2] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA
[3] Teva Branded Pharmaceut Prod R&D Inc, Frazer, PA USA
[4] Univ Duisburg Essen, Essen, Nordrhein Westf, Germany
来源：
HEADACHE | 2020年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [1] Pooled Analysis of Cardiovascular Safety With Fremanezumab Treatment in Patients With Migraine by Number of Cardiovascular or Cerebrovascular Risk Factors
    Juergens, T.
    Kessler, Y.
    Cohen, J. M.
    Ning, X.
    Yang, R.
    Diener, H. -C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 164 - 164
  • [2] Pooled Analysis of Cardiovascular Safety with Fremanezumab Treatment in Patients with Migraine by Cardiovascular History and Number of Cardiovascular or Cerebrovascular Risk Factors
    Nahas, Stephanie J.
    Juergens, Tim P.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Du, Evelyn
    Silberstein, Stephen D.
    [J]. ANNALS OF NEUROLOGY, 2020, 88 : S159 - S159
  • [3] CARDIOVASCULAR SAFETY OF FREMANEZUMAB IN PATIENTS WITH MIGRAINE AND CARDIOVASCULAR MEDICAL HISTORY OR RISK FACTORS: A POOLED ANALYSIS OF PHASE 3 STUDIES
    Nahas, Stephanie J.
    Jurgens, Tim P.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Du, Evelyn
    Silberstein, Stephen D.
    [J]. CEPHALALGIA, 2020, 40 : 96 - 96
  • [4] Cardiovascular Safety of Fremanezumab in Patients With Migraine and Cardiovascular Medical History or Risk Factors: A Pooled Analysis of Phase 3 Studies
    Nahas, Stephanie J.
    Jurgens, Tim P.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Du, Evelyn
    Silberstein, Stephen D.
    [J]. NEUROLOGY, 2021, 96 (15)
  • [5] Pooled Analysis of Cardiovascular Safety With Fremanezumab Treatment in Patients With Migraine and Concomitant Triptan Use
    Karppa, M.
    Ning, X.
    Kessler, Y.
    Cohen, J. M.
    Yang, R.
    Pazdera, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 295 - 295
  • [6] Pooled Analysis of Cardiovascular Safety With Fremanezumab Treatment in Patients With Migraine and Concomitant Triptan Use
    Karppa, M.
    Ning, X.
    Kessler, Y.
    Cohen, J. M.
    Yang, R.
    Pazdera, L.
    [J]. HEADACHE, 2020, 60 : 22 - 23
  • [7] POOLED ANALYSIS OF CARDIOVASCULAR SAFETY WITH FREMANEZUMAB TREATMENT IN PATIENTS WITH MIGRAINE AND CONCOMITANT CARDIOVASCULAR MEDICATION OR TRIPTAN USE AT BASELINE
    Coppola, Gianluca
    Ning, Xiaoping
    Kessler, Yoel
    Cohen, Joshua M.
    Du, Evelyn
    Barbanti, Piero
    [J]. CEPHALALGIA, 2020, 40 : 83 - 83
  • [8] Pooled Analysis of Safety and Tolerability with Fremanezumab Treatment in Patients with Migraine and Baseline Cardiovascular Medication or Concomitant Triptan Use
    Coppola, Gianluca
    Ning, Xiaoping
    Kessler, Yoel
    Cohen, Joshua M.
    Du, Evelyn
    Barbanti, Piero
    [J]. ANNALS OF NEUROLOGY, 2020, 88 : S155 - S155
  • [9] Cardiovascular Safety of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies
    Nahas, Stephanie J.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    Silberstein, Stephen D.
    [J]. NEUROLOGY, 2020, 94 (15)
  • [10] Pooled Analysis of Tolerability With Fremanezumab Treatment in Patients With Episodic or Chronic Migraine and Cardiovascular Medication Use at Baseline
    Coppola, G.
    Cohen, J. M.
    Ning, X.
    Kessler, Y.
    Yang, R.
    Barbanti, P.
    [J]. HEADACHE, 2020, 60 : 23 - 23
12345